ADPKD: molecular characterization and quest for treatment

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical and Experimental Nephrology

• Publication date

  2005-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10157-005-0367-6PMID 16362154
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Calcium Channel Blocker versus Angiotensin II Receptor Blocker in Autosomal Dominant Polycystic Kidney Disease

  2005cited by this paper
• Polycystic kidney disease.

  2004cited by this paper
• Aberrant Polycystin-1 Expression Results in Modification of Activator Protein-1 Activity, whereas Wnt Signaling Remains Unaffected*

  2004cited by this paper
• Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated Phenotype*

  2004cited by this paper
• Identification of Telmisartan as a Unique Angiotensin II: Receptor Antagonist With Selective PPARγ–Modulating Activity

  2004cited by this paper
• TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia

  2004cited by this paper
• Deficiency of polycystin‐2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells

  2004cited by this paper
• Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease

  2004cited by this paper
• Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis

  2003cited by this paper
• Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2

  2003cited by this paper
• How to make tubes: signaling by the Met receptor tyrosine kinase.

  2003cited by this paper
• Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

  2003cited by this paper
• Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype.

  2003cited by this paper
• Identification, Characterization, and Localization of a Novel Kidney Polycystin-1-Polycystin-2 Complex*

  2002cited by this paper
• The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein

  2002cited by this paper
• The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia.

  2002cited by this paper
• Modifier effect of ENOS in autosomal dominant polycystic kidney disease.

  2002cited by this paper
• Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant.

  2002cited by this paper
• A complete mutation screen of the ADPKD genes by DHPLC.

  2002cited by this paper
• Genetics and pathogenesis of polycystic kidney disease.

  2002cited by this paper
• Hepatocyte growth factor and the kidney

  2002cited by this paper
• The unexpected landscape of in vivo somatic mutation in a human epithelial cell lineage

  2002cited by this paper
• Cell Cycle via Direct Activation of the JAK-STAT Signaling Pathway in a Process Requiring PKD2

  2002cited by this paper
• Functional polycystin-1 expression is developmentally regulated during epithelial morphogenesis in vitro: downregulation and loss of membrane localization during cystogenesis.

  2002cited by this paper
• Polycystin-2 is an intracellular calcium release channel

  2002cited by this paper
• The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease.

  2002cited by this paper
• Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease.

  2002cited by this paper
• Genetics and Pathogenesis of Polycystic Kidney Disease

  2002cited by this paper
• Association of eNOS Glu298Asp Polymorphism With End-Stage Renal Disease

  2002cited by this paper
• Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis.

  2001cited by this paper
• Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease.

  2001cited by this paper
• Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples.

  2001cited by this paper
• Polycystin: new aspects of structure, function, and regulation.

  2001cited by this paper
• Polycystin-1 Interacts with Intermediate Filaments*

  2001cited by this paper
• Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications.

  2001cited by this paper
• Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects.

  2001cited by this paper
• Biochemical characterization of bona fide polycystin-1 in vitro and in vivo.

  2001cited by this paper
• Homologues to the first gene for autosomal dominant polycystic kidney disease are pseudogenes.

  2001cited by this paper
• Gab1 phosphorylation: a novel mechanism for negative regulation of HGF receptor signaling

  2001cited by this paper
• ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini

  2001cited by this paper
• Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel.

  2001cited by this paper
• Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.

  2001cited by this paper
• Polycystic kidney disease: In danger of being X-rated?

  2001cited by this paper
• Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene

  2001cited by this paper
• Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel

  2001cited by this paper
• Polycystin 1 is required for the structural integrity of blood vessels.

  2000cited by this paper
• cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells.

  2000cited by this paper
• Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells.

  2000cited by this paper
• Distinct and common developmental expression patterns of the murine Pkd2 and Pkd1 genes.

  2000cited by this paper
• Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents

  2000cited by this paper
• A road to kidney tubules via the Wnt pathway

  2000cited by this paper
• Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.

  2000cited by this paper
• cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.

  2000cited by this paper
• Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor.

  2000cited by this paper
• Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease.

  2000cited by this paper
• Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298.

  2000cited by this paper
• Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells.

  2000cited by this paper
• Vasopressin V(2)-receptor-dependent regulation of AQP2 expression in Brattleboro rats.

  2000cited by this paper
• Identification and Characterization of Polycystin-2, the PKD2 Gene Product*

  1999cited by this paper
• Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group.

  1999cited by this paper
• Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation

  1999cited by this paper
• Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.

  1999cited by this paper
• Cerebral aneurysms in patients with autosomal dominant polycystic kidney disease--to screen, to clip, to coil?

  1999cited by this paper
• Expression of Peroxisome Proferator-Activated Receptor γ (PPARγ) in Human Transitional Bladder Cancer and its Role in Inducing Cell Death

  1999cited by this paper
• Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease.

  1999cited by this paper
• Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins.

  1999cited by this paper
• Autosomal dominant polycystic kidney disease: clues to pathogenesis.

  1999cited by this paper
• The Polycystic Kidney Disease 1 Gene Product Modulates Wnt Signaling*

  1999cited by this paper
• Germinal and somatic mutations in the PKD2 gene of renal cysts in autosomal dominant polycystic kidney disease.

  1999cited by this paper
• Extrarenal manifestations of autosomal dominant polycystic kidney disease.

  1999cited by this paper
• Prevalence and Renal Prognosis of Diagnosed Autosomal Dominant Polycystic Kidney Disease in Japan

  1998cited by this paper
• Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells

  1998cited by this paper
• Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.

  1998cited by this paper
• Terminal differentiation of human breast cancer through PPAR gamma.

  1998cited by this paper
• A spectrum of mutations in the polycystic kidney disease-2 (PKD2) gene from eight Canadian kindreds.

  1998cited by this paper
• Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease.

  1998cited by this paper
• Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells.

  1998cited by this paper
• Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.

  1998cited by this paper
• Induction of epithelial tubules by growth factor HGF depends on the STAT pathway

  1998cited by this paper
• Vascular expression of polycystin-2.

  1997cited by this paper
• Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor.

  1997cited by this paper
• Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis.

  1997cited by this paper
• Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein.

  1997cited by this paper
• Distribution and developmentally regulated expression of murine polycystin.

  1997cited by this paper
• Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.

  1997cited by this paper
• PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

  1997cited by this paper
• Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

  1997cited by this paper
• Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts

  1996cited by this paper
• Characterization and Cell Distribution of Polycystin, the Product of Autosomal Dominant Polycystic Kidney Disease Gene 1

  1996cited by this paper
• Identification and localization of polycystin, the PKD1 gene product.

  1996cited by this paper
• Differential inhibition of mesangial MAP kinase cascade by cyclic nucleotides.

  1996cited by this paper
• PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein

  1996cited by this paper
• Chloride and fluid secretion by cultured human polycystic kidney cells.

  1996cited by this paper
• Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. The International Polycystic Kidney Disease Consortium.

  1995cited by this paper
• In vitro fluid secretion by epithelium from polycystic kidneys.

  1995cited by this paper
• AVP inhibits EGF-stimulated MAP kinase cascade in Madin-Darby canine kidney cells.

  1995cited by this paper
• Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD.

  1995cited by this paper
• The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains

  1995cited by this paper
• Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells.

  1995cited by this paper
• Mediation of renal cyst formation by hepatocyte growth factor.

  1994cited by this paper

• Polycystic kidney disease.

  2026cites this paper
• PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease

  2023cites this paper
• PKD1 Gene

  2020cites this paper
• Polycystic Kidney Disease

  2019cites this paper
• Potter Syndrome: A case study

  2017cites this paper
• Ganoderma triterpenes retard renal cyst development by downregulating Ras/MAPK signaling and promoting cell differentiation.

  2017cites this paper
• Clinical Scenarios in Chronic Kidney Disease: Cystic Renal Diseases.

  2016cites this paper
• Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies

  2013cites this paper
• Fresh from the designation pipeline: orphan drugs recently designated in the European Union (June – August 2013)

  2013cites this paper
• Evaluation of Dysmorphogenesis in Embryonic Kidney Induced by Calcium Channel Blockers

  2012cites this paper
• Human Evaluation of the Glu298Asp Polymorphism in NOS3 Gene and its Relationship with Onset age of ESRD in Iranian Patients Suffering from ADPKD

  2012cites this paper
• Tetracycline-induced renal failure after dental treatment.

  2009cites this paper
• Polycystic kidney disease

  2009cites this paper
• Clinical analyses of 75 parathyroidectomy (PTE) patients and 69 adrenalectomy (AE) patients including saliva-type amylase-secreting secondary parathyroid hyperplasia (SPTH) and insulinoma with adrenal adenoma (AA) showing primary aldosteronism

  2009cites this paper
• Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ.

  2008cites this paper
• Genetic and molecular regulation of epithelial tube morphogenesis

  2006cites this paper
• Chapter Murine Models for Polycystic Kidney Disease Towards Therapeutic Intervention Strategies for Polycystic Kidney Disease

  2006cites this paper
• Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation.

  2006cites this paper
• Polycystic kidney disease.

  2004cites this paper